• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Evonik

    Novo Strikes Up To $5.2B Deal For Akero In Red-Hot MASH Space

    BIOSPACE

    US Court Denies Novo Nordisk Challenge To Medicare Drug Pricing

    REUTERS

    Novo’s Cuts Leave Dozens of Manufacturing Workers Jobless

    REUTERS

    Skye`s CB1 Blocker Fails To Reduce Weight In Obesity Study

    FIERCE BIOTECH

    Lupin Launches Liraglutide Injection In US

    INDPHARMAPOST

    Novo plans online launch for Obesity Pill Once Approved

    REUTERS

    Novo Nordisk Vs. KBP: From $1.3B Deal To Legal Battlefield

    FIERCE BIOTECH

    European Doctors Recommend Novo And Lilly Weight-Loss Drugs

    ECONOMICTIMES

    Novo Calls Off $598M Heartseed Collab, Citing `strategic Reviews`

    FIERCE BIOTECH

    LIFMD Collaborates With Novo Nordisk, Offering Ozempic

    GLOBENEWSWIRE

    Novo Holdings-Backed Biotech Raises $205m To Fill Gout Care Gap

    FIERCE PHARMA

    Novo Nordisk Resubmits Awiqli® For FDA Approval As Weekly Insulin

    PR NEWSWIRE

    Novo Nordisk Submits BLA To FDA For Mim8 In Hemophilia A

    PR NEWSWIRE

    Weight-Loss Drug Ozempic To Debut In India Soon

    ECONOMICTIMES

    Roche`s Obesity Ambition Not Reliant on One Megablockbuster

    FIERCE BIOTECH

    Indian Pharma Prepares For ?600-800 Cr Insulin Pen Market

    BUSINESS STD

    Innovent`s Weight-Loss Drug Highlights China Challenge for Novo

    REUTERS

    Europe`s CHMP Approves Novo`s Kyinsu, Bayer`s Lynkuet

    FIERCE PHARMA

    Study: One-Third of Trial Data May Be Unnecessary

    FIERCE BIOTECH

    Novo Boosts Wegovy Pill Case Before FDA Decision

    FIERCE PHARMA

    Novo, BMS Layoffs Leave Over 500 Jobless in New Jersey

    BIOSPACE

    6 Pharma Layoffs Could Eliminate Over 39,000 Jobs

    BIOSPACE

    NJ layoffs: Novo Nordisk dismisses 263, BMS cuts 282 workers

    FIERCE PHARMA

    Indian Pharma Giants Dr Reddy`s and Macleods Gear Up for Ozempic

    ECONOMICTIMES

    Novo Says Wegovy Pill Shows Comparable Weight-Loss to Injectable

    REUTERS

    Novo Pushes Ahead with Amylin After Seeing Ph. 3 Tolerability

    FIERCE BIOTECH

    Novo Nordisk Unveils Phase 3 Data for Amylin Cagrilintide

    GLOBENEWSWIRE

    Novo Holdings in talks to buy into Surya Hospitals

    ECONOMICTIMES

    EU Approves Novo`s Oral Semaglutide, Reduce Cardiovascular Death

    GLOBENEWSWIRE

    Novo’s Wegovy Cuts Food Noise, Lifts Mental Well-Being

    GLOBENEWSWIRE

    Novo Nordisk Mandates Employee Office Return by Jan. 1

    FIERCE PHARMA

    Novo Nordisk Streamlines Operations for Growth Reinvestment

    GLOBENEWSWIRE

    Wegovy-Maker Novo to Slash 9,000 Jobs as Competition Heats Up

    REUTERS

    Novo, Lilly Obesity Drugs Deemed `Highly Cost-Effective` by ICER

    FIERCE PHARMA

    Novonesis, Novo Nordisk to Enhance Metabolic Health Solutions

    GLOBENEWSWIRE

    WHO Includes GLP-1s in Essential Medicines List

    BIOSPACE

    Europe Warns of Surge in Illegal Obesity Drugs

    FIERCE PHARMA

    Novo Nordisk to Unveil Semaglutide Data on `Food Noise`

    GLOBENEWSWIRE

    Novo Nordisk Partners with Apollo Clinics for Obesity Management

    ECONOMICTIMES

    Novo’s Wegovy Cuts Risk of Heart Attack or Death by 57%

    GLOBENEWSWIRE

    Novo`s Wegovy Cuts Heart Risk by 57% versus Rival Lilly Drug

    REUTERS

    Novo Seeks Obesity Refresh with $550 M Replicate Deal

    FIERCE BIOTECH

    Catalent`s Newly Acquired Novo Plant Under FDA Scrutiny

    FIERCE PHARMA

    CDSCO issues Alert on Novo Drugs After Reported Theft

    ECONOMICTIMES

    Natco Pharma Sues Novo Nordisk Over Generic Drug Push

    ECONOMICTIMES

    Drugmaker Novo Nordisk Freezes Hiring for Non-Critical Jobs

    REUTERS

    Parker Waichman Files Suit for Ozempic-Linked NAION Vision Loss

    PR NEWSWIRE

    Novo to Showcase Wegovy & Ozempic Benefits at ESC Congress 2025

    GLOBENEWSWIRE

    Canada Approves Ozempic to Cut Risk of Kidney Failure

    REUTERS

    Wegovy`s Approval Highlights Viability of High-Dose Peptides

    BIOSPACE

    Novo Nordisk A/S: Board Members and Executives Trade Shares

    GLOBENEWSWIRE

    BioMed X, Novo Nordisk Launch Oral Peptide Delivery Project

    CONTRACTPHARMA

    Novo Nordisk Unveils $499 Cash-Pay Ozempic Offering

    FIERCE PHARMA

    Novo Nordisk cuts Ozempic® price to $499/month for self-paying

    PR NEWSWIRE

    GoodRx, Novo Nordisk To Offer Ozempic And Wegovy At $499/Month

    BUSINESSWIRE

    Novo`s Wegovy Gets Accelerated Approval for Liver Disease MASH

    REUTERS

    Obesity Drug Heavyweights` Battle

    FIERCE PHARMA

    GLP-1s: The Cause of Novo Nordisk`s Swift Rise and Fall

    BIOSPACE

    Novo Nordisk A/S: Board Members, Executives Trade Shares

    GLOBENEWSWIRE

    Obesity Leaders Fortify Injectable GLP-1 Empires With Manufacture

    BIOSPACE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.